Ligand Pharmaceuticals reported $83.64M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Agenus AGEN:US $ 20.93M 5.01M
Amgen AMGN:US $ 6594M 356M
Anika Therapeutics ANIK:US $ 39.66M 2.96M
Arrowhead Research ARWR:US $ 32.41M 119.39M
Baxter International BAX:US $ 3746M 39M
Bristol Myers Squibb BMY:US $ 11887M 239M
Clovis Oncology CLVS:US $ 32.14M 2.1M
Eli Lilly And LLY:US $ 6488M 1322M
Enanta Pharmaceuticals ENTA:US $ 19.48M 0.76M
Endo International Ordinary Shares ENDP:US $ 569.11M 83.14M
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 6929M 2851M
Glaxosmithkline GSK:US $ 6929M 2851M
Harsco HSC:US $ 481.05M 28.26M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Immunogen IMGN:US $ 14.16M 23.92M
Insmed INSM:US $ 65.22M 12.11M
Intrexon XON:US $ 2.91M 29.11M
Karyopharm Therapeutics KPTI:US $ 39.68M 7.99M
Lannett LCI:US $ 78.36M 8.15M
Ligand Pharmaceuticals LGND:US $ 83.64M 37.95M
Macrogenics MGNX:US $ 26.01M 14.91M
Merk MRK:US $ 14593M 1308M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Pfizer PFE:US $ 27742M 2081M
Rigel Pharmaceuticals RIGL:US $ 29.82M 13.08M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
Veracyte VCYT:US $ 72.86M 5.08M